Multibagger Stock engaged in the business of production, processing, and marketing of high-quality hybrid seeds, Pesticides and many more, hit a 10 percent upper circuit in the day’s trade upon signing MOU worth Rs. 25 Crores to provide support to 12,500 farmer groups.
With a market capitalization of Rs. 149 Crores, the shares of Nirman Agri Genetics Limited hit a 10 percent upper circuit at Rs. 250.45. It has delivered multibagger returns of 146 percent in a year.
Nirman Agri Genetics Limited has entered into a memorandum of understanding (MOU) worth Rs. 25 Crores, with Gurusiddhi Farmer Producer Company Limited for providing seeds, pesticides, and new technologies to 12,500 farmer groups.
The MOU aims for the sale of Seeds and Pesticides and it will boost the company’s portfolio directly with farmers and farmers‐based entities to tap the maximum market.
Nirman Agri Genetics Limited is engaged in the business of production, processing, and marketing of high-quality hybrid seeds, Pesticides, micronutrients and Bio-organics for different varieties of crops.
Its revenue from operations grew by 112 percent from Rs. 13.49 Crores in FY22 to Rs. 28.61 Crores in FY23, accompanied by increasing profits of Rs. 2.56 Crores to Rs. 4.01 Crores.
It has reported a return on equity (ROE) of 27.1 percent and a return on capital employed (ROCE) of 26.6 percent, it is making good returns on its equity and capital
According to the latest shareholding data available for the quarter ended December 2023, the company’s Promoters hold a 66.05 percent stake in the company and the rest 33.95 percent is held by the public.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
